Results
1 -
10 of
15Tumor lysis syndrome in the era of novel and targeted agents in patients with hematologic malignancies: a systematic review, Annals of Hematology Proteasome Inhibitors in the Treatment of Multiple Myeloma and AL Amyloidosis, Resistance to Proteasome Inhibitors in Cancer Targeting the Proteasome Pathway for the Treatment of Solid Tumors, Resistance to Proteasome Inhibitors in Cancer Treatment of MM: Upcoming Novel Therapies, Plasma Cell Dyscrasias Overcoming Inherent Resistance to Proteasome Inhibitors in Head and Neck Cancer: Challenges and New Approaches, Resistance to Proteasome Inhibitors in Cancer Introduction, Structural and Functional Characterization of the Immunoproteasome Second-Generation Proteasome Inhibitors, Bortezomib in the Treatment of Multiple Myeloma Positioning of proteasome inhibitors in therapy of solid malignancies, Cancer Chemotherapy and Pharmacology Proteasome-associated deubiquitinases and cancer, Cancer and Metastasis Reviews